View Author
cancer patient stomach stomach cancer treatment study radiation chemotherapy stomach cancer risk m-cavi control oncology diagnosis hodgkin cisplatin testicular cancer testicular hodgkin lymphoma disease survival phase lymphoma response group case patients radiotherapy oncol oncology information downloaded toxicity gemcitabine stomach doses m-cavi arm trial survivor society factor american society radiation fi elds table procarbazine bajorin risk groups bajorin gc arm stomach dose smoking radiation dose analysis cohort van den belt-dusebout death reason grade 3 number grade erasmus mc firmed radiation doses /carboplatin firmed uncon firmed urothelial medische bibliotheek therapy case –control study para-aortic methotrexate bladder netherland mantle cisplatin-based chemotherapy month signi bajorin risk factors para-aortic fi eld result malignancy model information bladder cancer 0.0 randomized
2 Most Recent Publications
|
Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986
(Article)
Santis, M. de Bellmunt, J. Collette, S. Lorent, J. Wit, R. de Sylvester, R. Mead, G.M. Kerst, J.M. Leahy, M. Maroto, P. Gil, T. Marreaud, S. Daugaard, G. Skoneczna, I. |
2012-01-10
|
|
Roles of Radiation Dose and Chemotherapy in the Etiology of Stomach Cancer as a Second Malignancy
(Article)
Belt-Dusebout, A.W. van den Aleman, B.M.P. Gietema, J.A. Leeuwen, F.E. van Besseling, G. Bruin, M.L. de Hauptmann, M. Veer, M.B. van 't Wit, R. de Ribot, J.G. Noordijk, E.M. Kerst, J.M. |
2009-12-01
|